Definition and prevalence over the years of polypharmacy in Turkey: A systematic review

dc.authoridKara, Emre/0000-0002-7034-4787
dc.authoridKARA, EMRE/0000-0002-7034-4787
dc.authoridGöncüoğlu, Cansu/0000-0003-1415-4708
dc.authoridÖzdemir, Nesligül/0000-0003-2551-9549
dc.authorwosidKara, Emre/W-7305-2019
dc.authorwosidKARA, EMRE/E-3684-2018
dc.authorwosidGöncüoğlu, Cansu/GLR-3380-2022
dc.authorwosidÖzdemir, Nesligül/ABH-5503-2020
dc.contributor.authorGoncuoglu, Cansu
dc.contributor.authorOzdemir, Nesligul
dc.contributor.authorKara, Emre
dc.contributor.authorBayraktar-Ekincioglu, Aygin
dc.date.accessioned2024-08-04T20:10:21Z
dc.date.available2024-08-04T20:10:21Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstractIdentification of the trend of polypharmacy over the years is as valuable as determining the common definitions for taking precautions. The aim of this systematic review is to reveal the frequency, commonly used definitions and its change over the years of polypharmacy in Turkey. The reporting of this systematic review follows to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA 2020) checklist. The MEDLINE and ULAKBIM TR Dizin databases were searched for relevant studies published until April, 2021. The studies conducted with patients >18 years in Turkey were included. A total of 361 articles were identified and 52 articles met the inclusion criteria. The most common definition of polypharmacy was 'combination of 5 or more drugs', followed by the definitions of 'two or more drugs' to '10 or more drugs; and its prevalence ranged between 9% and 95% in the studies. It was determined that the most commonly used definition of polypharmacy was 'the use of 5 or more drugs'. The prevalence of polypharmacy in Turkey was appeared in a wide range and found higher than the studies in the literature. The prevalence and trends of polypharmacy over the years should be carefully observed, inappropriate use of medicines should be examined and necessary precautions should be taken accordingly.en_US
dc.identifier.doi10.29228/jrp.434
dc.identifier.endpage1487en_US
dc.identifier.issn2630-6344
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85165866838en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1474en_US
dc.identifier.trdizinid1189995en_US
dc.identifier.urihttps://doi.org/10.29228/jrp.434
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1189995
dc.identifier.urihttps://hdl.handle.net/11616/92737
dc.identifier.volume27en_US
dc.identifier.wosWOS:001037073200004en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherMarmara Univen_US
dc.relation.ispartofJournal of Research in Pharmacyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPolypharmacyen_US
dc.subjectInappropriate prescribingen_US
dc.subjectDefinitionen_US
dc.subjectPrevalenceen_US
dc.subjectSystematic reviewen_US
dc.titleDefinition and prevalence over the years of polypharmacy in Turkey: A systematic reviewen_US
dc.typeReview Articleen_US

Dosyalar